Pharmacokinetic validation of a new protocol of chronic oral administration of aripiprazole in male C57 Bl/6 mice through drinking solution

This publication has 36 references indexed in Scilit:

• Micropipette-guided Drug Administration (MDA) as a non-invasive chronic oral administration method in male rats
  Journal of Neuroscience Methods, 2023
• Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia
  Behavioural Brain Research, 2022
• Augmented improvement of cognition and memory by aripiprazole add-on for cilostazol treatment in the chronic cerebral hypoperfusion mouse model
  Behavioural Brain Research, 2019
• The antipsychotic aripiprazole selectively prevents the stimulant and rewarding effects of morphine in mice
  European Journal of Pharmacology, 2014
• Efficacy and safety of aripiprazole in child and adolescent patients
  European Child & Adolescent Psychiatry, 2012
• Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice
  Neuropharmacology, 2010
• Aripiprazole brain concentration is altered in P-glycoprotein deficient mice
  Schizophrenia Research, 2009
• The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice
  Alcohol, 2008
• Variables affecting prepulse inhibition of the startle reflex and the response to antipsychotics in DBA/2NCrl mice
  Psychopharmacology, 2007
• Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex
  Neuroscience Letters, 2005